Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
18,988,397
-
Share change
-
+5,643,290
-
Total reported value
-
$608,887,000
-
Put/Call ratio
-
17%
-
Price per share
-
$32.05
-
Number of holders
-
73
-
Value change
-
+$194,251,789
-
Number of buys
-
54
-
Number of sells
-
22
Institutional Holders of SIERRA ONCOLOGY INC - COM NEW (SRRA) as of Q1 2022
As of 31 Mar 2022,
SIERRA ONCOLOGY INC - COM NEW (SRRA) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,988,397 shares.
The largest 10 holders included
Vivo Capital, LLC, Frazier Life Sciences Management, L.P., ORBIMED ADVISORS LLC, Rock Springs Capital Management LP, PFM Health Sciences, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Paradigm Biocapital Advisors LP, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, and BlackRock Inc..
This page lists
73
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.